Milkha Singh Admitted to ICU Due to Drop in Oxygen Levels

Milkha Singh Admitted to ICU Due to Drop in Oxygen Levels Late legendary sprinter Milkha Singh- (PTI Photo)

Chandigarh: Legendary Indian sprinter Milkha Singh, who recently contracted Covid-19 infection, on Thursday was admitted to the Intensive Care Unit (ICU) of a top hospital in Chandigarh due to “dipping levels of oxygen” but he is in “stable” condition.

“Flying Sikh Milkha Singh has been admitted in ICU in Covid hospital of PGIMER today due to dipping levels of oxygen,” a statement issued by Post-Graduate Institute of Medical Education and Research (PGIMER) here said. It further said that the 91-year-old has been kept under observation and is “stable now”.

ALSO READ: Legendary sprinter Milkha Singh hospitalised after drop in oxygen level due to Covid

Earlier on Sunday, Milkha Singh was discharged from a private hospital in Mohali where he received treatment for Covid-19 infection. He, however, continued to be on oxygen support at home also. A statement issued by Fortis hospital in Mohali, where he was earlier admitted, had said that the legend was discharged “in a stable condition on the request of his family”.

Milkha Singh on May 24 was admitted to Fortis Hospital after his SPO2 levels dropped. Singh had tested positive on May 20.

READ ALSO: COVID-19 positive Milkha Singh responding well to treatment, informs son Jeev

Milkha’s 82-year-old wife Nirmal Kaur, who had also contracted Covid-19 days after her husband got the infection, continues to be in the ICU of the Fortis hospital. The Fortis hospital had earlier said that the couple were being treated for Covid pneumonia. The couple’s son and ace golfer Jeev had earlier flown down to Chandigarh from Dubai while his elder sister, Mona Milkha Singh, who is a physician in the United States, had also reached here after their parents contracted the infection. Milkha is suspected to have contracted the infection from a house help.

(With inputs from PTI)

For the latest News, Breaking News, Top News, like us on Facebook or follow us on Twitter and YouTube